Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
Helus Pharma appointed Regina Donohue as Chief People Officer and Dr. Suresh Durgam to its Scientific Advisory Board, bringing on executives from Intra-Cellular Therapies. Donohue will lead people strategy and scaling efforts, while Durgam adds regulatory and clinical development expertise following his role in securing FDA approvals for CAPLYTA.
Key figures
- Hlp003 status
- Phase 3 clinical development for adjunctive treatment of MDD
- Hlp004 status
- Phase 2 for GAD
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.